查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1650737

RNA 分析/轉錄組學的全球市場

RNA Analysis / Transcriptomics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 504 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球 RNA 分析轉錄組學市場規模將達到 190 億美元

2024 年全球 RNA 分析轉錄組學市場規模估計為 89 億美元，預計到 2030 年將達到 190 億美元，2024-2030 年分析期間的複合年成長率為 13.4%。 RNA 分析轉錄組學試劑/耗材是報告中分析的細分市場之一，預計到分析期結束時複合年成長率為 14.5%，達到 97 億美元。在分析期內，RNA 分析轉錄組學儀器部分的複合年成長率預計為 11.9%。

美國市場預估達 33 億美元，中國市場複合年成長率達 14.4%

預計2024年美國RNA分析轉錄組學市場價值將達33億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 16 億美元，2024-2030 年分析期間的複合年成長率為 14.4%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 11.5% 和 13.3%。在歐洲，預計德國的複合年成長率約為 13.2%。

全球 RNA 分析轉錄組學市場 - 主要趨勢和促進因素摘要

RNA 分析，也稱為轉錄組學，是分子生物學中一個強大且重要的領域，專注於研究細胞和生物體內的 RNA 分子。轉錄組學透過檢查 RNA 轉錄本（DNA 和蛋白質之間的中間體）的豐度和序列來深入了解基因表現和調控。該分析對於了解細胞功能、識別疾病的生物標記和發現潛在的治療目標至關重要。在轉錄組學中，RNA序列測定（RNA-Seq）、微陣列和定量PCR（qPCR）等方法通常用於測量和比較不同條件和發育階段的RNA水平。這些方法使研究人員能夠建立基因表現的綜合概況，並闡明生物過程和疾病機制的複雜性。

技術進步大大提高了 RNA 分析的能力和應用。高通量定序技術，尤其是 RNA-Seq，能夠在基因組範圍內對 RNA 轉錄物進行準確、全面的定量，從而徹底改變了轉錄組學。與傳統方法相比，RNA-Seq 提供了更詳細、更公正的轉錄組視圖，能夠檢測新的轉錄物、剪接變異體和非編碼 RNA。此外，單細胞 RNA 定序（scRNA-Seq）已成為一項革命性的技術，可在單細胞層級進行基因表現分析，以前所未有的解析度揭示細胞異質性和細胞過程的動態。計算工具和生物資訊學的進步也在轉錄組學中發揮了重要作用，為資料分析、整合和解釋提供了框架，使研究人員能夠從複雜的資料集中獲得有意義的生物學見解。

RNA 分析/轉錄組學市場的成長受到多種因素的推動，包括個人化醫療需求的不斷增加、定序技術的進步以及慢性病和癌症盛行率的上升。個人化醫療的轉變旨在根據個人的基因特徵制定治療方案，這推動了對全面轉錄組分析的需求，以確定特異性的生物標記和治療標靶。定序技術的不斷改進提高了準確性、通量和成本效益，使得轉錄組研究更容易進行並實現更廣泛的應用。此外，慢性病和癌症發生率的上升導致人們專注於這些病理的分子基礎，從而推動轉錄組學在研究和臨床環境中的實施。政府對基因組學研究的措施和資助，以及學術機構和製藥公司之間的合作也促進了市場的擴張。因此，RNA 分析/轉錄組學領域有望實現顯著成長，持續的創新和應用有望增進我們對生物學的理解並改善醫療保健結果。

部分

產品（試劑/耗材、儀器、服務、軟體）；技術（聚合酵素鏈鎖反應、定序、微陣列、 RNA干擾）；應用（藥物研發、毒理基因體學、臨床診斷、比較轉錄組學）

受訪企業範例（總合115家值得關注的企業）

  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • bioMerieux SA
  • Analytik Jena AG
  • Ambry Genetics
  • Advanced Cell Diagnostics, Inc.
  • Bioneer Corporation
  • BioChain Institute, Inc.
  • Akoya Biosciences, Inc.
  • Acobiom
  • ADS Biotec, Inc.
  • BGI Genomics Co Ltd.
  • 10X Genomics
  • Biois Co Ltd
  • Bertin Technologies, Sas

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP15286

Global RNA Analysis / Transcriptomics Market to Reach US$19.0 Billion by 2030

The global market for RNA Analysis / Transcriptomics estimated at US$8.9 Billion in the year 2024, is expected to reach US$19.0 Billion by 2030, growing at a CAGR of 13.4% over the analysis period 2024-2030. RNA Analysis / Transcriptomics Reagents / Consumables, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$9.7 Billion by the end of the analysis period. Growth in the RNA Analysis / Transcriptomics Instruments segment is estimated at 11.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Billion While China is Forecast to Grow at 14.4% CAGR

The RNA Analysis / Transcriptomics market in the U.S. is estimated at US$3.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 14.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.5% and 13.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.2% CAGR.

Global RNA Analysis / Transcriptomics Market - Key Trends & Drivers Summarized

RNA analysis, also known as transcriptomics, is a powerful and essential field in molecular biology that focuses on the study of RNA molecules within a cell or organism. Transcriptomics provides insights into gene expression and regulation by examining the quantity and sequences of RNA transcripts, which are the intermediates between DNA and proteins. This analysis is crucial for understanding cellular functions, identifying biomarkers for diseases, and discovering potential therapeutic targets. Techniques such as RNA sequencing (RNA-Seq), microarrays, and quantitative PCR (qPCR) are commonly used in transcriptomics to measure and compare RNA levels across different conditions or stages of development. These methods allow researchers to construct comprehensive profiles of gene expression, shedding light on the complexities of biological processes and disease mechanisms.

Technological advancements have significantly enhanced the capabilities and applications of RNA analysis. High-throughput sequencing technologies, particularly RNA-Seq, have revolutionized transcriptomics by enabling the precise and comprehensive quantification of RNA transcripts on a genome-wide scale. RNA-Seq provides a more detailed and unbiased view of the transcriptome compared to traditional methods, allowing for the detection of novel transcripts, splice variants, and non-coding RNAs. Additionally, single-cell RNA sequencing (scRNA-Seq) has emerged as a transformative technique that allows for the analysis of gene expression at the single-cell level, revealing cellular heterogeneity and the dynamics of cellular processes with unprecedented resolution. Advances in computational tools and bioinformatics have also played a crucial role in transcriptomics, providing the necessary frameworks for data analysis, integration, and interpretation, thus enabling researchers to derive meaningful biological insights from complex datasets.

The growth in the RNA analysis/transcriptomics market is driven by several factors, including the increasing demand for personalized medicine, advancements in sequencing technologies, and the rising prevalence of chronic diseases and cancer. The shift towards personalized medicine, which aims to tailor treatments based on an individual’s genetic profile, has spurred the need for comprehensive transcriptomic analysis to identify disease-specific biomarkers and therapeutic targets. Continuous improvements in sequencing technologies, resulting in higher accuracy, throughput, and cost-effectiveness, have made transcriptomic studies more accessible and feasible for a broader range of applications. Additionally, the rising incidence of chronic diseases and cancer has increased the focus on understanding the molecular underpinnings of these conditions, driving the adoption of transcriptomics in research and clinical settings. Government initiatives and funding for genomics research, along with collaborations between academic institutions and pharmaceutical companies, are also contributing to the market's expansion. As a result, the RNA analysis/transcriptomics field is poised for significant growth, with ongoing innovations and applications promising to enhance our understanding of biology and improve healthcare outcomes.

SCOPE OF STUDY:

The report analyzes the RNA Analysis / Transcriptomics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Reagents / Consumables, Instruments, Services, Software); Technology (Polymerase Chain Reaction, Sequencing, Microarray, RNA Interference); Application (Drug Discovery, Toxicogenomics, Clinical Diagnostics, Comparative Transcriptomics)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Select Competitors (Total 115 Featured) -

  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • bioMerieux SA
  • Analytik Jena AG
  • Ambry Genetics
  • Advanced Cell Diagnostics, Inc.
  • Bioneer Corporation
  • BioChain Institute, Inc.
  • Akoya Biosciences, Inc.
  • Acobiom
  • ADS Biotec, Inc.
  • BGI Genomics Co Ltd.
  • 10X Genomics
  • Biois Co Ltd
  • Bertin Technologies, Sas

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Economic Update
    • RNA-Oriented Projects Set to Increase
    • Competition
    • RNA Analysis / Transcriptomics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • What is RNA-Seq Technology?
    • A Prelude to Transcriptomics Technologies
    • Global Market Prospects & Outlook
    • PCR Emerges as the Leading Technology
    • Drug Discovery Segment Poised to Lead the Global Market
    • North America Emerges as the Major Regional Market
    • World Brands
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Trend Towards Personalized Medicine Fuels Market Growth
    • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
    • Drug Ineffectiveness for Select Therapeutic Categories as a Percentage of Patient Population
    • Transcriptomics Assume Critical Importance amid Growing Prevalence of Chronic Diseases
    • World Diabetes and Population Statistics (2021, 2030 & 2045)
    • World Diabetes Prevalence (2000-2045)
    • Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • Burden of Neurological Diseases: Deaths Per 100,000 Population due to Neurological Conditions in Select Countries
    • Transcriptomics Applications in Disease and Diagnostic Profiling
    • Increasing PCR Applications in Biotechnology Sector
    • Progressive Growth of Omics Technologies: Opportunity for RNA Analysis/Transcriptomics Market
    • The Growing Role of Transcriptomics in Oncology
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • RNA Sequencing Critical for Cancer and Rare Diseases
    • Bulk-Tissue RNA Sequencing and Single-Cell RNA Sequencing for Cardiovascular Research
    • Bulk RNA Sequencing
    • Single-Cell Sequencing
    • Spatial Transcriptomics
    • Single-Cell RNA-seq Technologies Witness Steady Growth
    • The Evolution of scRNA-seq
    • Growth of Long-Read Transcriptome Sequencing
    • scRNA-seq for Autoimmune Inflammatory Rheumatic Diseases
    • SPLiTseq Beneficial for Understanding Cause of Disease
    • Gene Expression Microarray Technology Gains Ground
    • Microfluidics-based Droplet Technologies Demonstrate Growth
    • inDrops Approach Exhibits Growth
    • Spatial Transcriptomics Market Witnesses Significant Growth
    • Spatial Transcriptomic Data Analysis
    • Next Generation Sequencing Offers Increased Accuracy for Transcriptomics Activity
    • Single-cell NGS Witnesses Rapid Growth
    • RNA Sequencing Benefits Fuel Market Prospects
    • Blood Transcriptome Sequencing for Identifying Rare-Disease Genes
    • Rising Focus on Toxicogenomics: Potential for RNA Analysis/Transcriptomics Markets
    • Growing R&D Spending in Pharma and Biotechnology Sectors Presents Opportunities
    • Pharmaceutical R&D Spending Worldwide (USD Billion) for 2015-2025
    • Technological Advancements & Innovations Fuel Market Growth
    • Sci-Plex - A New Technique to Profile Gene Expression within Single Cells
    • Introduction of Oxford Nanopore's Innovative Portable Sequencer for Sequencing Long Reads and RNA Molecules Improves Transcriptomic Analysis
    • RNA-Combine, a Toolkit for More Comprehensively Analyzing Transcriptome Data
    • Aging Demographics Present Opportunities for Transcriptomics Technologies
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Challenges Facing RNA/Transcriptomics Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for RNA Analysis / Transcriptomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for RNA Analysis / Transcriptomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Reagents / Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Reagents / Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Reagents / Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Microarrays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for RNA Interference by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for RNA Interference by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for RNA Interference by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Toxicogenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Toxicogenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Toxicogenomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 36: World 15-Year Perspective for Clinical Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Comparative Transcriptomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Comparative Transcriptomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 39: World 15-Year Perspective for Comparative Transcriptomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 40: World RNA Analysis / Transcriptomics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • RNA Analysis / Transcriptomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030
  • JAPAN
    • TABLE 59: Japan Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030
  • CHINA
    • RNA Analysis / Transcriptomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030
  • EUROPE
    • RNA Analysis / Transcriptomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for RNA Analysis / Transcriptomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for RNA Analysis / Transcriptomics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030
  • FRANCE
    • TABLE 89: France Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030
  • GERMANY
    • TABLE 98: Germany Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • TABLE 116: UK Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • RNA Analysis / Transcriptomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of World 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030

IV. COMPETITION